These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8390730)

  • 1. Resolution by erythrocytapheresis of the exposure of an Rh-negative person to Rh-positive cells: an alternative treatment.
    Werch J; Todd C
    Transfusion; 1993 Jun; 33(6):530-2. PubMed ID: 8390730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB
    J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprophylactic anti-Rho(D) treatment after mismatched transfusions.
    Ennker J; Maas DH; Schneider J
    Eur J Obstet Gynecol Reprod Biol; 1979 Apr; 9(2):117-24. PubMed ID: 233744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

  • 9. Why women are not receiving anti-Rh prophylaxis.
    Tovey LA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):508. PubMed ID: 3030482
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of D isoimmunization. ACOG Technical Bulletin number 147--October 1990.
    Int J Gynaecol Obstet; 1992 Jan; 37(1):53-6. PubMed ID: 1346604
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).
    Anderson B; Shad AT; Gootenberg JE; Sandler SG
    Am J Hematol; 1999 Mar; 60(3):245-7. PubMed ID: 10072121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L; Napier JA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Rh incompatible transfusion after use of anti-D immunoglobulin for unexpected intraoperative massive hemorrhage].
    Kanazawa M; Nakagawa K; Hamano N; Nishi K; Shingu K
    Masui; 2013 Apr; 62(4):458-61. PubMed ID: 23697202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.
    Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M
    Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevention of Rh immunization.
    Bowman JM
    Transfus Med Rev; 1988 Sep; 2(3):129-50. PubMed ID: 2856526
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
    Bowman JM
    Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
    Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
    J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.